| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.079 | 0.2 |